Literature DB >> 22205659

Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan.

Makiko Sakikawa1, Shunichi Noda, Masachi Hanaoka, Hirotoshi Nakayama, Satoshi Hojo, Shigeko Kakinoki, Maki Nakata, Takashi Yasuda, Tsuyomu Ikenoue, Toshiyuki Kojima.   

Abstract

Toxoplasmosis is a zoonosis caused by infection with Toxoplasma gondii and is prevalent worldwide under various climatic conditions. It is usually asymptomatic, but infection in pregnant women can pose serious health problems for the fetus. However, epidemiological information regarding toxoplasmosis in Japanese pregnant women is limited. This study aimed to determine the prevalence of anti-Toxoplasma antibodies, the primary infection rate, and the risk factors for toxoplasmosis in Japanese pregnant women. We measured anti-Toxoplasma antibody titers in 4,466 pregnant women over a period of 7.5 years and simultaneously conducted interviews to identify the risk factors for toxoplasmosis. The overall prevalence of anti-Toxoplasma antibodies was 10.3%, and it was significantly higher in women aged above 35 years. The rate of primary Toxoplasma infection during pregnancy was estimated to be 0.25%. A possibility of infection in the later stages of pregnancy was identified for those women who were not infected in the early stages. A history of raw meat intake was identified to be a risk factor related to toxoplasmosis. Therefore, to lower the risk of toxoplasmosis, pregnant women should refrain from eating raw and undercooked meat and maintain personal hygiene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205659      PMCID: PMC3294603          DOI: 10.1128/CVI.05486-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

1.  Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil.

Authors:  Silvia Maria Spalding; Maria Regina Reis Amendoeira; Carlos Henrique Klein; Luis Carlos Ribeiro
Journal:  Rev Soc Bras Med Trop       Date:  2005-03-30       Impact factor: 1.581

2.  Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies.

Authors:  M Paul; E Petersen; J Szczapa
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America.

Authors:  Fernando Rosso; Jessica T Les; Alejandro Agudelo; Carlos Villalobos; José A Chaves; Gloria Anais Tunubala; Adriana Messa; Jack S Remington; José G Montoya
Journal:  Am J Trop Med Hyg       Date:  2008-03       Impact factor: 2.345

4.  Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.

Authors:  M H Bessières; A Berrebi; M Rolland; M C Bloom; C Roques; S Cassaing; C Courjault; J P Séguéla
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-01       Impact factor: 2.435

5.  Congenital toxoplasmosis in France in 2007: first results from a national surveillance system.

Authors:  I Villena; T Ancelle; C Delmas; P Garcia; A P Brezin; P Thulliez; M Wallon; L King; V Goulet
Journal:  Euro Surveill       Date:  2010-06-24

6.  Serological screening for antenatal toxoplasma infection in India.

Authors:  S Khurana; R Bagga; A Aggarwal; V Lyngdoh; K Diddi; N Malla
Journal:  Indian J Med Microbiol       Date:  2010 Apr-Jun       Impact factor: 0.985

Review 7.  Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection.

Authors:  Efrat Rorman; Chen Stein Zamir; Irena Rilkis; Hilla Ben-David
Journal:  Reprod Toxicol       Date:  2005-11-28       Impact factor: 3.143

8.  Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.

Authors:  Kenneth M Boyer; Ellen Holfels; Nancy Roizen; Charles Swisher; Douglas Mack; Jack Remington; Shawn Withers; Paul Meier; Rima McLeod
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

Review 9.  Management of Toxoplasma gondii infection during pregnancy.

Authors:  Jose G Montoya; Jack S Remington
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil.

Authors:  Ivana S Varella; Ivete C T Canti; Breno R Santos; Angela Z Coppini; Luciana C Argondizzo; Carina Tonin; Mário B Wagner
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

View more
  27 in total

1.  Seroprevalence of human Toxoplasma gondii infection among pregnant women in Charsadda, KP, Pakistan.

Authors:  Shah Faisal; Hasnain Jan; Muhammad Haroon; Muhammad Taimur Khan; Farman Ullah Jan; Tanveer Iqbal; Ayyaz Khan; Muhammad Shakeel
Journal:  J Parasit Dis       Date:  2018-10-15

2.  Clinical characteristics and computed tomography findings of pulmonary toxoplasmosis after hematopoietic stem cell transplantation.

Authors:  Masahiko Sumi; Kazumi Norose; Kenji Hikosaka; Hiroko Kaiume; Wataru Takeda; Takehiko Kirihara; Taro Kurihara; Keijiro Sato; Toshimitsu Ueki; Yuki Hiroshima; Hiroshi Kuraishi; Masahide Watanabe; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2016-08-16       Impact factor: 2.490

3.  Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka.

Authors:  Nilmini Chandrasena; Rasika Herath; Nawamalika Rupasinghe; Buddhini Samarasinghe; Hasaranga Samaranayake; Anuradhani Kastuririratne; Nilanthi Renuka de Silva
Journal:  Pathog Glob Health       Date:  2016-04-19       Impact factor: 2.894

4.  Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo.

Authors:  Yobi Doudou; Piarroux Renaud; L'Ollivier Coralie; Franck Jacqueline; Situakibanza Hypolite; Muhindo Hypolite; Mitashi Patrick; Inocêncio da Luz Raquel Andreia; Marc Van Sprundel; Boelaert Marleen; Jean-Pierre Van Geertruyden; Lutumba Pascal
Journal:  Asian Pac J Trop Biomed       Date:  2014-01

5.  Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

Authors:  M Perry Markovich; T Shohat; I Riklis; R Avni; D Yujelevski-Rozenblit; R Bassal; D Cohen; E Rorman
Journal:  Epidemiol Infect       Date:  2013-04-15       Impact factor: 4.434

6.  Comparison of Toxoplasma gondii Seroprevalence in Shelter Cats and Dogs during 1999-2001 and 2009-2011 in Tokyo, Japan.

Authors:  Masaaki Oi; Souichi Yoshikawa; Soichi Maruyama; Sadao Nogami
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

7.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

8.  Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand.

Authors:  Hemah Andiappan; Veeranoot Nissapatorn; Nongyao Sawangjaroen; Waenurama Chemoh; Yee Ling Lau; Thulasi Kumar; Subashini Onichandran; Chitkasaem Suwanrath; Verapol Chandeying
Journal:  Parasit Vectors       Date:  2014-05-22       Impact factor: 3.876

9.  Comparative study on Toxoplasma infection between Malaysian and Myanmar pregnant women.

Authors:  Hemah Andiappan; Veeranoot Nissapatorn; Nongyao Sawangjaroen; Myat Htut Nyunt; Yee-Ling Lau; Si Lay Khaing; Khin Myo Aye; Nan Cho Nwe Mon; Tian-Chye Tan; Thulasi Kumar; Subashini Onichandran; Noor Azmi bin Mat Adenan
Journal:  Parasit Vectors       Date:  2014-12-12       Impact factor: 3.876

10.  TORCH Antibodies Among Pregnant Women and Their Newborns Receiving Care at Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

Authors:  Aliasgher M Saajan; Mramba Nyindo; Joshua G Gidabayda; Mohammed S Abdallah; Shaneabbas H Jaffer; Aliasgher G Mukhtar; Tima M Khatibu; Rune Philemon; Grace D Kinabo; Blandina T Mmbaga
Journal:  East Afr Health Res J       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.